Patent · US Active

Purified double negative T cell and preparation and use thereof

US12398369B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

BEIJING IMMUTECH LLC · CN

Inventors

Dong ZHANG · Beijing, CN
Yanbing Zhu · Shanghai, CN
Lu Yang · Beijing, CN
Dan Tian · Nanhu, CN
Song Wang · Beijing, CN
Guangyong Sun · Beijing, CN

Key dates

Filing date	Apr 28, 2020
Grant date	Aug 26, 2025
Priority date	—
Expiry date	Sep 2, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is a DNT cell population with IL-17 secretory cells removed and a preparation method therefor and the use thereof. The DNT cell population has the effects of inhibiting T cell proliferation and inducing apoptosis, can inhibit the inflammation of adipose tissue, improve insulin resistance, alleviate diabetes, and relieve steatohepatitis, and can also be used for preventing and treating antigen-specific allergic asthma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.